TITLE

Putting the news in context

AUTHOR(S)
Tosh, Mark
PUB. DATE
January 2004
SOURCE
Medical Marketing & Media;Jan2004, Vol. 39 Issue 1, p6
SOURCE TYPE
Trade Publication
DOC. TYPE
Editorial
ABSTRACT
Provides information concerning the Medicare industry in the U.S. Medicare drug law recently signed by U.S. President George W. Bush; Impact of the legislation on the entire industry; Advice on how to maintain operating profits at the levels investor have come to expect.
ACCESSION #
11919238

 

Related Articles

  • on fiscal wake-up tours and toothless tigers. Wilensky, Gail R. // hfm (Healthcare Financial Management);Jun2008, Vol. 62 Issue 6, p38 

    The article reflects on the U.S. Medicare trustees' annual report released in March, 2008. The Part A of trust fund reportedly will be depleted of funds by 2019. It informs that Part B and Part D of Medicare fund cannot be depleted as it is funded by the U.S. Treasury, but it opines that they...

  • Prescription Drugs: Increasing Medicare Beneficiary Access and Related Implications: T-HEHS/AIMD-00-100. Scanlon, William J. // GAO Reports;2/16/2000, p1 

    Focuses on increasing of Medicare and beneficiary access to prescription drugs in the U.S. Gaps in the Medicare program; Long-term cost measures facing the Medicare program.

  • Ensuring Access to Affordable Drug Coverage in Medicare. Antos, Joseph R. // Health Care Financing Review;Winter2005, Vol. 27 Issue 2, p103 

    The long-awaited outpatient prescription drug benefit in Medicare began January 2006. Despite its importance, the drug benefit is controversial. Instead of paying directly for prescriptions, the program will operate through competing private plans. Although it is too early to assess the full...

  • Perspectives one year after implementation of the Medicare Prescription Drug Improvement and Modernization Act: A socratic panel discussion. Brill, Joel V.; Siegel, Jerry; Buffington, Daniel E.; Downs, Christian // American Journal of Health-System Pharmacy;8/1/2007 Supplement, Vol. 64, pS16 

    The article presents a panel discussion on the implementation of the Medicare Prescription Drug Improvement and Modernization Act in the U.S. Several medical professionals and experts discusses their views on various health care aspects that will be affected by the Act's implementation,...

  • "Welcome to Medicare" visits. Newby, Joy; Card, Randall O. // Family Practice Management;Jul2005, Vol. 12 Issue 7, p14 

    Presents a letter to the editor, commenting on the article "How to Conduct a 'Welcome to Medicare' Visit," published in the April 2005 article of the magazine "Family Practice Management."

  • Test Your M0110 -- Episode Timing Skills With These Scenarios.  // Eli's OASIS Alert;Sep2012, Vol. 13 Issue 9, p100 

    The article presents questions and answers related to Outcome & Assessment Information Set (OASIS) item M0110 including the payment episode of the agency whether early or later, representing distinct episodes for answering M0110, and the adjustment made by Medicare to correct the response.

  • Everyone a patient. Ross, Warren // Medical Marketing & Media;Dec2004, Vol. 39 Issue 12, p100 

    The article informs that when the U.S. DTC promotion makes people with hidden health problems go to the doctor, everyone agrees that's a good thing. Once the Medicare drug benefit kicks in and helps the elderly pay for their prescriptions, that too is considered a good thing. But put these...

  • Remunerating private psychiatrists for participating in case conferences. Pirkis, Jane E; Headey, Alan N; Burgess, Philip M; Whiteford, Harvey A; White, Josh P; Francis, Catherine // Australia & New Zealand Health Policy (ANZHP);2005, Vol. 2, p33 

    Background: On 1 November 2000, a series of new item numbers was added to the Medicare Benefits Schedule, which allowed for case conferences between physicians (including psychiatrists) and other multidisciplinary providers. On 1 November 2002, an additional set of numbers was added, designed...

  • Physicians seek solutions to Medicare system. Charters, Lynda // Ophthalmology Times;1/15/2006, Vol. 31 Issue 2, p1 

    The article focuses on the inability of Medicare to meet the demand for retina care specialists in the United States. This is due to the advent of treatments with proven efficacy for age-related macular degeneration. Increase medical costs are due to the drugs and the need for physician services...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics